| __timestamp | Supernus Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 24518692 |
| Thursday, January 1, 2015 | 89204000 | 19886580 |
| Friday, January 1, 2016 | 106010000 | 12631689 |
| Sunday, January 1, 2017 | 137905000 | 21977998 |
| Monday, January 1, 2018 | 159888000 | 20759000 |
| Tuesday, January 1, 2019 | 158425000 | 20838000 |
| Wednesday, January 1, 2020 | 200677000 | 121812000 |
| Friday, January 1, 2021 | 304759000 | 152137000 |
| Saturday, January 1, 2022 | 377221000 | 83231000 |
| Sunday, January 1, 2023 | 336361000 | 122706000 |
Infusing magic into the data realm
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Supernus Pharmaceuticals, Inc. and TG Therapeutics, Inc. have taken different paths in optimizing these costs. From 2014 to 2023, Supernus Pharmaceuticals saw a steady increase in SG&A expenses, peaking at 377 million in 2022, reflecting a growth of over 400%. In contrast, TG Therapeutics maintained a more conservative approach, with expenses rising to 152 million in 2021, a 520% increase from 2014. This divergence highlights the strategic choices each company makes in balancing growth and cost efficiency. As the industry evolves, these insights offer a glimpse into how biopharma companies can navigate financial challenges while striving for innovation.
Comparing SG&A Expenses: Amgen Inc. vs TG Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Zoetis Inc. vs TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Genmab A/S and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs TG Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and TG Therapeutics, Inc.
Breaking Down SG&A Expenses: Grifols, S.A. vs TG Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
Comparing Revenue Performance: TG Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.?
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Veracyte, Inc.
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.